Skip to content
Companies

DesiCorp

Freeze-dried red blood cells stored without refrigeration

Raised to date

$3.5M

of $6M offered across 2 Form D filings

Still open
$2.5M
Investors
8
Last filed
Jun 9, 2026

About

DesiCorp is a Louisville, Kentucky biotechnology company that applies anhydrobiosis science to make blood products, vaccines and other biologics stable at room temperature. Its patented ultrasonic process loads trehalose into red blood cells so they can be freeze-dried and later rehydrated, removing the cold chain from transfusion medicine. The technology originated in research at the University of Louisville and has been funded through SBIR/STTR awards and state matching funds. The company also supplies rehydration packaging and domestic manufacturing for shelf-stable healthcare products.

A patented ultrasonic intracellular trehalose delivery process that makes packed red blood cells freeze-dryable and shelf-stable without refrigeration, extending viability from weeks of cold storage to long-term ambient storage for battlefield, disaster and rural use.

Funding

  • EquityFiled Jun 9, 2026Form D/A
    $3.5M/ $6M
  • EquityFiled Apr 1, 2026Form D
    $840K/ $5M

Product

Thermally stable freeze-dried packed red blood cells

Blood product / biologics preservation

Human packed red blood cells stabilized by ultrasonic-mediated intracellular delivery of trehalose and then freeze-dried, producing a powder that stores without refrigeration and is rehydrated at the point of care for transfusion.

  • Patented ultrasonic process for intracellular trehalose loading
  • No refrigeration required for storage or transport
  • Extended shelf life versus weeks for conventional cold-stored blood

Built for

Military and defense medical programs, plus disaster-relief organizations, rural and remote clinics, and biotech partners needing shelf-stable cell products

People on file